Tier 2 · Liquid 3000
Cullinan Therapeutics, Inc.
CGEM · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.
Price
$21.82
+0.00%
Coverage
Tier 2
Tier 2 · Liquid 3000
SEC CIK
0001789972
Liquidity rank
#2327
Observed dollar volume
SEC XBRL facts
| Field | Value | Period end | Filing |
|---|---|---|---|
| Annual revenue | Not published | Not published | No matching frame |
| Annual diluted EPS | Not published | Not published | No matching frame |
| Quarterly revenue | Not published | Not published | No matching frame |
| Quarterly diluted EPS | Not published | Not published | No matching frame |
SEC EDGAR Frames batch generated 2026-08-24T22:57:10.505Z. Frames are calendar-aligned and may not cover every filer or fiscal period.
Dividends
Trailing 12 months
Not published
Latest payment
Not published
Yahoo Finance corporate actions. Window: 2025-08-25 through 2026-08-25.
Seasonality
| Month | Mean return | Positive | n |
|---|
Monthly close-to-close returns, trailing 15 years where Yahoo history is available.
Sector news
Health Care Roundup: Market Talk - WSJWSJ · 2026-08-25
Q2 2026 Healthcare Antitrust and Competition Update - JD SupraJD Supra · 2026-08-24
BPOC backs medical equipment firms MME and ReNew Biomedical - DealroomDealroom · 2026-08-24
RPC Acquires Peracidin Product Line From Angelini Pharma To Expand Dialysis And Water Treatment Portfolio - Pulse 2.0Pulse 2.0 · 2026-08-24
Medical malpractice risk in a changing market - LaingBuisson NewsLaingBuisson News · 2026-08-25
Filings and machine access
Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract
Context paths
HealthcareNasdaqBMY · Tier 1 peerDHR · Tier 1 peerISRG · Tier 1 peerPFE · Tier 1 peer
Provenance
Quote and corporate actionsYahoo Finance chart
FundamentalsSEC EDGAR Frames